Novosana and LUS partner to grow vegan omega-3 market
Novosana produces Dmax algal DHA 400 which provides a minimum of 400mg/g of DHA and is claimed to have the industry lowest TOTOX values.
The omega-3 giant is now working with LUS, a firm committed to sustainable and plant-based ingredients, to launch a range of concepts throughout 2020, including vegan soft gels with 250mg DHA, Omega 3to1 DHA-to-EPA formulas as well as a vegan solution for the popular cod liver supplements.
The future is sustainable
A recent study by Colombo et al pointed out that DHA from Fish origin might be in danger because of global warming. Scientists estimated that an increase in water temperature could impact the de novo synthesis of DHA in the algae at top of the food chain. This drop in DHA synthesis may result in a 10-58% loss of globally available DHA.
Novosana argues that products like Dmax 400 algal oil provide the sustainable solution to provide DHA for the future generations
Bas Arntz, VP Business Development and Operations of Novosana, said: "Novosana is very proud to announce the partnership with LUS. With the innovative approach of LUS we can grow the Vegan Omega 3 market. As vegan Omega 3 will be the future for several industries, we are sure that LUS is the right partner.
"LUS is able to connect to the market and grow the number of Omega 3 consumers. Vegan is not only a trend for Novosana, it will be a strong pillar for the company and for the global Omega 3 market development."
René Van Hoorn, founder & CEO of Lus Health Ingredients, added: "We believe in algal oil, as the product for those consumers who want to add DHA as an essential fatty acid to their diet from the most direct natural form that algae are.
"The strong relationship with Novosana means we can grow this market even faster than we first anticipated.“
